The primary endpoint was a composite of major cardiovascular events (MACE), including acute myocardial infarction, stroke, and CV failure
About Wegovy HD (semaglutide) injection 7.2 mg The FDA approval of Wegovy HD is based on the results of the STEP UP program, which included the phase 3 STEP UP clinical trial, which was a 72-week randomized, double-blinded, placebo-controlled and active-controlled superiority trial designed to evaluate the efficacy and safety of once-weekly semaglutide injection 7.2 mg compared to semaglutide injection 2.4 mg and placebo as an adjunct to lifestyle intervention
A review of your other medications with your healthcare provider may also be beneficial
Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
We refuse to use ingredients that can inhibit absorption